Evaluation of Drug-Induced QT Interval ProlongationImplications for Drug Approval and Labelling

被引：0
|
作者：
Marek Malik
A. John Camm
机构：
[1] St George’s Hospital Medical School,Department of Cardiological Sciences
来源：
Drug Safety | 2001年 / 24卷
关键词：
Moxifloxacin; Cisapride; Terfenadine; Cardiac Toxicity; Sparfloxacin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Assessment of proarrhythmic toxicity of newly developed drugs attracts significant attention from drug developers and regulatory agencies. Although no guidelines exist for such assessment, the present experience allows several key suggestions to be made and an appropriate technology to be proposed.
引用
收藏
页码：323 / 351
页数：28
相关论文
共 50 条
  • [31] Perianesthesia Implications and Considerations for Drug-Induced QT Interval Prolongation
    Aroke, Edwin N.
    Nkemazeh, Rolland Z.
    JOURNAL OF PERIANESTHESIA NURSING, 2020, 35 (02) : 104 - 111
  • [32] Drug-induced QT interval prolongation: mechanisms and clinical management
    Nachimuthu, Senthil
    Assar, Manish D.
    Schussler, Jeffrey M.
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2012, 3 (05) : 241 - 253
  • [33] Drug-induced proarrhythmic effects: assessment of changes in QT interval
    Sheridan, DJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 50 (04) : 297 - 302
  • [34] Drug-induced prolongation of the QT interval: why the regulatory concern?
    Shah, R.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 53 - 53
  • [35] Drug-induced QT prolongation
    Wooten, James M.
    SOUTHERN MEDICAL JOURNAL, 2006, 99 (01) : 16 - 16
  • [36] Drug-induced QT prolongation
    Michowitz, MK
    Michowitz, Y
    Zaidenstein, R
    Golik, A
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2000, 2 (12): : 924 - 928
  • [37] Drug-induced QT prolongation
    Tzivoni, D
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2001, 3 (06): : 472 - 472
  • [38] A polygenic risk score for the QT interval is an independent predictor of drug-induced QT prolongation
    Simon, Steven T.
    Lin, Meng
    Trinkley, Katy E.
    Aleong, Ryan
    Rafaels, Nicholas
    Crooks, Kristy R.
    Reiter, Michael J.
    Gignoux, Christopher R.
    Rosenberg, Michael A.
    PLOS ONE, 2024, 19 (06):
  • [39] Identification of "toxicophoric" features for predicting drug-induced QT interval prolongation
    Coi, Alessio
    Massarelli, Ilaria
    Testai, Lara
    Calderone, Vincenzo
    Bianucci, Anna Maria
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2008, 43 (11) : 2479 - 2488
  • [40] Drug-Induced QT Interval Prolongation: Clinical, Safety and Regulatory Update
    Di Girolamo, Guillermo
    CURRENT DRUG SAFETY, 2010, 5 (01) : 41 - 43
12345